Home/WinSanTor/Nigel Calcutt

NC

Nigel Calcutt

Founding KOL

Therapeutic Areas

Peripheral Neuropathy Diabetic Complications Oncology Supportive Care HIV Complications

WinSanTor Pipeline

Drug	Indication	Phase
WST-057	Peripheral Neuropathy (Diabetic, Chemo-Induced, HIV-Induced)	Phase 3

Leadership Team at WinSanTor

Chief Executive Officer

Paul Fernyhough

Co-Founder, Founding KOL

View full WinSanTor profile